Ram Prasad Sahu

Stories by Ram Prasad Sahu

Watch out for these stocks this monsoon

Watch out for these stocks this monsoon

Rediff.com   28 Apr 2017

What stocks will gain from a normal monsoon?

Jio could slash telcos' FY18 operating profit

Jio could slash telcos' FY18 operating profit

Rediff.com   19 Apr 2017

Falling revenues, increased capex, and first full year of spectrum debt may make things worse

Jio's new plans will add to Airtel, Voda's woes

Jio's new plans will add to Airtel, Voda's woes

Rediff.com   22 Feb 2017

Revenues of Airtel and Idea have been hit by falling realisation and analysts said margins would be affected by higher costs.

Partnership with Jio a virtual merger: Anil Ambani

Partnership with Jio a virtual merger: Anil Ambani

Rediff.com   28 Sep 2016

Ambani said, in the telecom space, the focus will be on debt reduction, and the virtual merger did away with the need for major capex and will help towards this

Godrej Properties: BKC deal a big positive

Godrej Properties: BKC deal a big positive

Rediff.com   2 Oct 2015

Almost a third of the company's capex was stuck in this project

Oberoi, Phoenix, Godrej to outrun peers at Dalal Street

Oberoi, Phoenix, Godrej to outrun peers at Dalal Street

Rediff.com   24 Sep 2015

Godrej Properties, is on the horizon as it unlocks value in its high-value Bandra-Kurla Complex (BKC) project.

The secret behind IndiGo's success

The secret behind IndiGo's success

Rediff.com   15 Sep 2015

Given its network and fleet, it has garnered the highest share of passenger growth.

Q1 results: No earnings relief for India Inc yet

Q1 results: No earnings relief for India Inc yet

Rediff.com   27 Jul 2015

The reason is believed to be a 19% increase in interest cost.

No sunshine for Sun Pharma in FY16

No sunshine for Sun Pharma in FY16

Rediff.com   22 Jul 2015

Brokerages have cut the company's FY16 earnings estimates between 16% and 29% with target prices too coming down to the Rs 700-800 band

Why are domestic investors writing off pharma stocks these days

Why are domestic investors writing off pharma stocks these days

Rediff.com   19 May 2015

FIIs are looking at the long-term story and initiatives of Indian pharma companies to transform themselves into global entities.

Street's faith in tariff hikes by telcos may be misplaced

Street's faith in tariff hikes by telcos may be misplaced

Rediff.com   30 Apr 2015

Telcos have indicated that rates will have to be raised, as higher volumes alone will not suffice to meet the higher costs.

Integration challenges: Sun Pharma's next hurdle

Integration challenges: Sun Pharma's next hurdle

Rediff.com   23 Apr 2015

The challenge of merging Ranbaxy into the company has not been factored in.

Stocks that hit record highs and lows in FY15

Stocks that hit record highs and lows in FY15

Rediff.com   3 Apr 2015

It was a year of big gains for equity investors.

Tata Motors: Short term worries but outlook strong

Tata Motors: Short term worries but outlook strong

Rediff.com   19 Mar 2015

Given the better growth in JLR sales and improving domestic sales, nearly 90 per cent of the analysts covering the stock have a 'Buy' rating.

10 stocks that can bring you a fortune in 2015

10 stocks that can bring you a fortune in 2015

Rediff.com   2 Jan 2015

Half of the sharp rise in stocks in 2014 was driven by re-ratings - rise in price-to-earning ratios on hopes the new government would turn around the economy which will reflect in corporate earnings.

Maruti all geared to hitch a smooth ride in 2015

Maruti all geared to hitch a smooth ride in 2015

Rediff.com   2 Jan 2015

Maruti has improved its sales in the recent past.

Stay invested but hedge your bets

Stay invested but hedge your bets

Rediff.com   31 Dec 2014

Have a Plan B in place if the tide turns against you.

Maruti all set for a smooth ride on the back of new launches

Maruti all set for a smooth ride on the back of new launches

Rediff.com   10 Dec 2014

Maruti is expected to post double-digit growth on product launches and good demand for entry-level cars.

More pain ahead for DLF stock after Sebi ban

More pain ahead for DLF stock after Sebi ban

Rediff.com   15 Oct 2014

Since the cash flows will be impacted in a big way, DLF will have to resort to selling non-core assets in a substantial and significant manner through the next few quarters.

10 mid-cap stocks that can give you attractive returns

10 mid-cap stocks that can give you attractive returns

Rediff.com   3 Oct 2014

More, many market gurus expect the Sensex to reach 30,000 levels by December and 40,000-45,000 in three to four years.